Compliance Department. GSK shall include a summary of the Non-Promotional Monitoring Program and the results of the Non-Promotional Monitoring Program as part of each Annual Report. As part of each Annual Report, GSK also shall provide the OIG with descriptions of any instances identified through the Non-Promotional Monitoring Program in which it was determined that improper promotion of Government Reimbursed Products occurred or the activities violated GSK’s requirements or Policies and Procedures, and a description of the action(s) that GSK took as a result of such determinations. GSK shall make the documents relating to the Non-Promotional Monitoring Program available to the OIG upon request. GlaxoSmithKline LLC Corporate Integrity Agreement
Compliance Department. As a backup precaution, the Company may also make direct contact with the Client. The deposit will be immediately cancelled, and the funds will be refunded to the credit card in the case the deposit is determined to be high-risk or does not comply with the Company’s Fraud and Security policies. In addition, it is at the Company’s sole discretion to close any (and all) of your accounts with the Company in such cases. Any active orders will be cancelled immediately if associated with the same fraudulent card and/or account and any profits or revenues may be seized.
Compliance Department. Corporate Integrity Agreement AstraZeneca AstraZeneca shall include a summary of the FFMP and the results of the FFMP as part of each Annual Report. As part of each Annual Report, AstraZeneca also shall provide the OIG with copies of the Observation report for any instances in which it was determined that improper promotion occurred and a description of the action(s) that AstraZeneca took as a result of such determinations. AstraZeneca shall make the Observation reports for all other Observations available to the OIG upon request.
Compliance Department. As a backup precaution, the Company may also make direct contact with the Client. The deposit will be immediately cancelled, and the funds will be refunded to the credit card in the case the deposit is determined to be high-risk or does not comply with the Company’s Fraud and Security policies. In addition, it is at the Company’s sole discretion to close any (and all) of your accounts with the Company in such FXGlobe Ltd · +000 00000000 · xxxx@xxxxxxx.xxx · 0 Xxxxx Xxxxxx Xxxxxx, Limassol, 3030, Cyprus cases. Any active orders will be cancelled immediately if associated with the same fraudulent card and/or account and any profits or revenues may be seized.
Compliance Department. Company reserves the right in its sole discretion to decline the enrollment of Provider for any reason.
Compliance Department. Novartis shall include a summary of the Non-Promotional Monitoring Program and the results of the Non-Promotional Monitoring Program as part of each Annual Report. As part of each Annual Report, Novartis also shall provide the OIG with descriptions of any instances identified through the Non-Promotional Monitoring Program in which it was determined that improper promotion of Government Reimbursed Products occurred or the activities violated Novartis’ requirements or Policies and Procedures, and a description of the action(s) that Novartis took as a result of such determinations. Novartis shall make the documents relating to the Non-Promotional Monitoring Program available to the OIG upon request. Novartis Pharmaceuticals Corporation Corporate Integrity Agreement
Compliance Department. Continental Stock Transfer & Trust Company September 29, 2008 Except as expressly set forth above, the Rights Agreement remains effective without modification. This letter agreement may be signed in two counterparts, which together will constitute a single agreement. Please indicate acceptance of the foregoing by signing where indicated below. PERMA-FIX ENVIRONMENTAL SERVICES, INC. By: /s/Xxxxxx Xxxxxxxx Xxxxxx X. Xxxxxxxx Chief Financial Officer Dated: September 29, 2008 CONTINENTAL STOCK TRANSFER & TRUST COMPANY /s/Xxxxxxxxx Xxxxxxxx Xxxxxxxxx Xxxxxxxx, Vice President and Senior Account Manager Dated: September 29, 2008
Compliance Department. Any and all notices given to a Record Holder of a Receipt hereunder or under the Depositary Receipts shall be in writing and shall be deemed to have been duly given if personally delivered or sent by mail or by telecopy confirmed by letter, addressed to such Record Holder at the address of such Record Holder as it appears on the books of the Depositary, or if such holder shall have filed with the Depositary a written request that notices intended for such holder be mailed to some other address, at the address designated in such request.
Compliance Department. PCL will establish a Compliance Department, headed by the Corporate Compliance Officer, which will be responsible for monitoring the compliance of all PCL employees with this Agreement, the CIP, the Standards of Conduct set forth in the PCL Corporate Integrity Policy Manual, and all reimbursement, billing and fraud and abuse laws and regulations applicable to participants in federally-funded health care programs, including pertinent provisions of the following: Title XVIII of the Social Security Act, 42 U.S.C. ss.sx. 0095-1395ddd (the Medicare statute); Title XIX of the Social Security Act, 42 U.S.C. ss.sx. 0096-1396v (the Medicaid statute); the Clinical Laboratory Improvement Amendments ("CLIA") of 1988, 42 U.S.C. ss. 263a; the Medicare/Medicaid Anti-Kickback Statute, 42 U.S.C. ss. 1320a-7b(b); the False Claims Act, 31 U.S.C. ss.sx. 0029-33 (as amended); the Program Fraud
Compliance Department. Email: xxxxxxxxxx@Xxxxxx.xxx Schedule 1 – Definitions In this agreement the following words and phrases have the following meanings: Access Codes Means the username and password, or any other credentials provided by us to you for accessing your Account and trading through our electronic systems, the security of which is your sole responsibility and the use of which and any damage caused by any act or omission is your sole responsibility.
